Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 41 Amendments

1 Hold­ers of a li­cence must ap­ply to Swiss­med­ic with the ne­ces­sary doc­u­ment­a­tion for any amend­ments to the con­tent of the li­cence.

2 They must re­port the es­sen­tial de­tails of all ma­jor changes to fa­cil­it­ies, equip­ment or pro­ced­ures used in the man­u­fac­ture, test­ing or im­port and ex­port of medi­cin­al products, for whole­sale trad­ing or in trad­ing abroad with medi­cin­al products or for broker­age or agency activ­it­ies in con­nec­tion with medi­cin­al products and which could in­flu­ence qual­ity.

3 Swiss­med­ic shall re­spond to ap­plic­a­tions un­der para­graph 1 and make any ob­jec­tions to amend­ments as in para­graph 2 with­in a peri­od of 30 days.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden